NS6180
CAS No. 353262-04-1
NS6180 ( NS6180; NS-6180; NS 6180 )
Catalog No. M14204 CAS No. 353262-04-1
NS6180 is a novel potent and selective KCa3.1 channel inhibitor(IC50= 9 nM) prevents T-cell activation and inflammation.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 38 | In Stock |
|
5MG | 58 | In Stock |
|
10MG | 97 | In Stock |
|
25MG | 212 | In Stock |
|
50MG | 347 | In Stock |
|
100MG | 516 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNS6180
-
NoteResearch use only, not for human use.
-
Brief DescriptionNS6180 is a novel potent and selective KCa3.1 channel inhibitor(IC50= 9 nM) prevents T-cell activation and inflammation.
-
DescriptionNS6180 is a novel potent and selective KCa3.1 channel inhibitor(IC50= 9 nM) prevents T-cell activation and inflammation.
-
SynonymsNS6180; NS-6180; NS 6180
-
PathwayCell Cycle/DNA Damage
-
TargetPotassium Channel
-
RecptorKCa3.1 channel
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number353262-04-1
-
Formula Weight323.33
-
Molecular FormulaC16H12F3NOS
-
Purity>98%(HPLC)
-
SolubilityDMSO: 100 mM
-
SMILESO=C1CSC2=CC=CC=C2N1CC3=CC=CC(C(F)(F)F)=C3
-
Chemical Name4-[[3-(Trifluoromethyl)phenyl]methyl]-2H-1,4-benzothiazin-3(4H)-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Strobak D, et al. Br J Pharmacol. 2013 Jan;168(2):432-44.
molnova catalog
related products
-
Iptakalim Hydrochlor...
Iptakalim, a lipophilic para-amino compound, is a novel ATP-sensitive potassium channel (KATP) opener, as well as an α4β2-containing nicotinic acetylcholine receptor (nAChR) antagonist.
-
NS-3623
A novel human RBC Cl-conductance blocker (IC50=210 nM) and HERG channel activitor (EC50=79.4 uM, HERG1 channel activation).
-
GAL-021
A novel respiratory stimulant that acts as a potent calcium-activated potassium (BKCa) channel blocker blocker.